Exscientia achieves milestones for two programmes in sanofi collaboration

Oxford, england--(business wire)--exscientia plc (nasdaq: exai) today announced the advancement of two additional discovery programmes within its collaboration with sanofi, with exscientia receiving an aggregate of $15 million in milestone payments. both lead compounds have met the product profile requirements, set by both exscientia and sanofi, to enable a transition to the lead optimisation phase within the collaboration. both programmes have also shown a high level of differentiation in earl.
EXAI Ratings Summary
EXAI Quant Ranking